Cyclopentenylcytosine does not enhance cisplatin-induced radiosensitization in human lung tumour cells
- PMID: 22966339
- PMCID: PMC3436402
- DOI: 10.3892/ol_00000095
Cyclopentenylcytosine does not enhance cisplatin-induced radiosensitization in human lung tumour cells
Abstract
The search for agents that enhance the effect of ionizing radiation has been an object of study for decades. In this study, the sensitizing properties of cyclopentenylcytosine (CPEC) on radiation and cisplatin-induced radiosensitization in human squamous lung carcinoma cells were investigated. Human lung tumour SW-1573 cells (SWp, parental; SWg, gemcitabine-resistant) were incubated with CPEC and cisplatin and subsequently irradiated with different doses of γ-rays. Clonogenic survival was determined to measure the effectiveness of the treatments. CPEC (1 or 2 μM) treatment for 4 h decreased the plating efficiency to 75 and 50% in SWp and SWg cells, respectively. In the SWg cells, 0.1 and 1 μM CPEC for 4 h enhanced the cell killing effect of cisplatin. However, an increase was not noted in the SWp cells. Due to the moderate toxicity of 1 μM for 4 h, this CPEC dose was used in the radiosensitization experiments. However, CPEC neither radiosensitized the lung tumour cells nor enhanced the radiosensitizing effect of cisplatin. A 2-h incubation with 4 μM cisplatin also decreased the plating efficiency to 75-80% in the two cell lines. Using this cisplatin dose, radiosensitization was obtained in the two cell lines. Although cisplatin treatment clearly radiosensitized the lung tumour cells, CPEC treatment did not. Cisplatin-induced radiosensitization was also not enhanced by CPEC.
Figures
References
-
- Gharehbaghi K, Zhen W, Fritzer-Szekeres M, Szekeres T, Jayaram HN. Studies on the antitumour activity and biochemical actions of cyclopentenyl cytosine against human colon carcinoma HT-29 in vitro and in vivo. Life Sci. 1999;64:103–112. - PubMed
-
- Gharehbaghi K, Szekeres T, Yalowitz JA, Fritzer-Szekeres M, Pommier YG, Jayaram HN. Sensitizing human colon carcinoma HT-29 cells to cisplatin by cyclopentenylcytosine, in vitro and in vivo. Life Sci. 2000;68:1–11. - PubMed
-
- Van Bree C, Barten-van Rijbroek AD, Leen R, Rodermond HM, van Kuilenburg AB, Kal HB. Cyclopentenyl cytosine has biological and anti-tumour activity, but does not enhance the efficacy of gemcitabine and radiation in two animal tumour models. Int J Oncol. 2009;34:813–819. - PubMed
-
- Kang GJ, Cooney DA, Moyer JD, Kelley JA, Kim HY, Marquez VE, Johns DG. Cyclopentenylcytosine triphosphate. Formation and inhibition of CTP synthetase. J Biol Chem. 1989;264:713–718. - PubMed
LinkOut - more resources
Full Text Sources